FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jürgen Rockstroh

Research Profile

Disorders

Procedures

Living Beings

Chemicals & Drugs

Concepts & Ideas

Physiology

Viral Drug Resistance

Co-author Network

Publications

TOP 3
Carolynne Schwarze-Zander; Jürgen K Rockstroh
HIV protease inhibitors in combination with boceprevir: are drug-drug interactions the same for all patients?
Hannah Koppitz; Hans Konrad Müller-Hermelink; Jürgen K Rockstroh; Heinrich Schüller; Dirk Skowasch; Jens Standop; Ingo G H Schmidt-Wolf
State-of-the-art classification and multimodality treatment of malignant thymoma.
Edwin DeJesus; Mark J DiNubile; Adriano Lazzarin; Randi Leavitt; Jeffrey Lennox; Michael Miller; Bach-Yen Nguyen; Jürgen K Rockstroh; Anthony J Rodgers; Michael S Saag; Peter Sklar; Hedy Teppler; Monica L Walker; Hong Wan; Jing Zhao
Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jürgen Rockstroh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Carolynne Schwarze-Zander; Jürgen K Rockstroh
HIV protease inhibitors in combination with boceprevir: are drug-drug interactions the same for all patients?
AIDS (London, England) 2012;26(14):1845-6.
2012: Hannah Koppitz; Hans Konrad Müller-Hermelink; Jürgen K Rockstroh; Heinrich Schüller; Dirk Skowasch; Jens Standop; Ingo G H Schmidt-Wolf
State-of-the-art classification and multimodality treatment of malignant thymoma.
Cancer treatment reviews 2012;38(5):540-8.
2012: Edwin DeJesus; Mark J DiNubile; Adriano Lazzarin; Randi Leavitt; Jeffrey Lennox; Michael Miller; Bach-Yen Nguyen; Jürgen K Rockstroh; Anthony J Rodgers; Michael S Saag; Peter Sklar; Hedy Teppler; Monica L Walker; Hong Wan; Jing Zhao
Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK.
HIV clinical trials 2012;13(4):228-32.
2012: Martin Vogel; Jan-Christian Wasmuth; Axel Baumgarten; Christoph Boesecke; Stefan Mauss; Mark Nelson; Emma Page; Thomas Reiberger; Jürgen K Rockstroh; Carolynne Schwarze-Zander
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(4):556-9.
2012: Stefan Reuter; Jürgen K Rockstroh; Gerd Fätkenheuer; Rolf Kaiser; Heribert Knechten; Thomas Lengauer; Mark Oette; Dieter Häussinger
Risk factors associated with older age in treatment-naive HIV-positive patients.
Intervirology 2012;55(2):147-53.
2011: Jürgen K Rockstroh; Anthony Rodgers; Michael S Saag; Peter Sklar; Hedy Teppler; Monica L Walker; Hong Wan; Xia Xu; Jing Zhao; Edwin DeJesus; Mark J DiNubile; Adriano Lazzarin; Randi Leavitt; Jeffrey Lennox; Bach-Yen Nguyen
Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(8):807-16.
2011: P Lutz; Hans Dieter Nischalke; Johannes Oldenburg; Jürgen K Rockstroh; Tilman Sauerbruch; Frank Grünhage; Frank Lammert; N Vidovic; Jan-Christian Wasmuth; Ulrich Spengler
Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B gene.
European journal of medical research 2011;16(8):335-41.
2011: Christoph Boesecke; Jürgen K Rockstroh
Treatment of acute hepatitis C infection in HIV-infected patients.
Current opinion in HIV and AIDS 2011;6(4):278-84.
2011: Martin Vogel; Jürgen K Rockstroh
[HAART-update for the general practitioner].
MMW Fortschritte der Medizin 2011;153(18):32-4.
2011: Markus Neibecker; Carolynne Schwarze-Zander; Jürgen K Rockstroh; Ulrich Spengler; Jason T Blackard
Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany.
Journal of medical virology 2011;83(4):685-94.
2011: Martin Vogel; O Friedrich; G Lüchters; B Holleczek; Jan-Christian Wasmuth; E Anadol; Carolynne Schwarze-Zander; Jacob Nattermann; Johannes Oldenburg; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence.
European journal of medical research 2011;16(3):101-7.
2011: Jacob Nattermann; Martin Vogel; Hans Dieter Nischalke; Mark Danta; Stefan Mauss; Hans-Jürgen Stellbrink; Axel Baumgarten; Christoph Mayr; Raffaele Bruno; Cristina Tural; Gerd Klausen; Bonaventura Clotet; Uwe Naumann; Thomas Lutz; Michael Rausch; Knud Schewe; Bernhard Bienek; Georg Haerter; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C.
The Journal of infectious diseases 2011;203(5):595-601.
2011: Martin Vogel; Christoph Boesecke; Jürgen K Rockstroh
Acute hepatitis C infection in HIV-positive patients.
Current opinion in infectious diseases 2011;24(1):1-6.
2011: Christian Körner; Benjamin Krämer; Jacob Nattermann; Katarina Riesner; Jürgen K Rockstroh; Daniela Schulte; Felix Tolksdorf; Ulrich Spengler
Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
Antiviral therapy 2011;16(7):1047-55.
2011: Jürgen K Rockstroh; Lars Peters; Heiner Wedemeyer
Is there a need for liver disease monitoring in HIV patients in Africa?
Antiviral therapy 2011;16(3):287-9.
2010: Carolynne Schwarze-Zander; Sabine Becker; Jörg Wenzel; Jürgen K Rockstroh; Ulrich Spengler; AF Yassin
Bacteremia caused by a novel helicobacter species in a 28-year-old man with X-linked agammaglobulinemia.
Journal of clinical microbiology 2010;48(12):4672-6.
2010: Martin Vogel; Thijs van de Laar; Bernd Kupfer; Hans-Jürgen Stellbrink; Tim Kümmerle; Stefan Mauss; Gaby Knecht; Annemarie Berger; Sylvia Bruisten; Jürgen K Rockstroh
Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany.
Liver international : official journal of the International Association for the Study of the Liver 2010;30(8):1169-72.
2010: Martin Vogel; Carolynne Schwarze-Zander; Jan-Christian Wasmuth; Ulrich Spengler; Tilman Sauerbruch; Jürgen K Rockstroh
The treatment of patients with HIV.
Deutsches Ärzteblatt international 2010;107(28-29):507-15; quiz 516.
2010: M Vogel; C Boesecke; J-C Wasmuth; Jürgen K Rockstroh
[HIV and hepatitis C co-infection].
Deutsche medizinische Wochenschrift (1946) 2010;135(23):1186-91.
2010: E Anadol; Rolf Kaiser; J Verheyen; E Schülter; J Emmelkamp; Carolynne Schwarze-Zander; Bernd Kupfer; Jan-Christian Wasmuth; Jürgen K Rockstroh
Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications?
European journal of medical research 2010;15(5):225-30.
2010: Martin Vogel; Norbert Bertram; Jan-Christian Wasmuth; J Emmelkamp; Jürgen K Rockstroh; Christoph Reichel
Determination of nevirapine in plasma by GC-MS.
Journal of chromatographic science 2010;48(2):91-4.
2010: Carolynne Schwarze-Zander; Markus Neibecker; Sabrina Othman; Cristina Tural; Bonaventura Clotet; Jason T Blackard; Bernd Kupfer; Guido Luechters; Raymond T Chung; Jürgen K Rockstroh; Ulrich Spengler
GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells.
Antiviral therapy 2010;15(5):745-52.
2010: Jürgen K Rockstroh; Jose Gatell; Roland Landman; Andrea Antinori
Management of late-presenting patients with HIV infection.
Antiviral therapy 2010;15 Suppl 1():25-30.
2010: Martin Vogel; Stéphanie Dominguez; Sanjay Bhagani; Alex Azwa; Emma Page; Marguerite Guiguet; Marc-Antoine Valantin; Christine Katlama; Jürgen K Rockstroh; Mark Nelson
Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort.
Antiviral therapy 2010;15(2):267-79.
2010: Martin Vogel; Jürgen K Rockstroh
Treatment of acute hepatitis C in HIV infection.
The Journal of antimicrobial chemotherapy 2010;65(1):4-9.
2009: Jürgen K Rockstroh
Integrase inhibitors: why do we need a new drug class for HIV therapy?
European journal of medical research 2009;14 Suppl 3():1-3.
2009: Daniela Schulte; Martin Vogel; Bettina Langhans; Benjamin Krämer; Christian Körner; Hans Dieter Nischalke; Verena Steinberg; Monika Michalk; Thomas Berg; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann
The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells.
The Journal of infectious diseases 2009;200(9):1397-401.
2009: Christian Körner; Benjamin Krämer; Daniela Schulte; Martin Coenen; Stefan Mauss; Gerd Fätkenheuer; Johannes Oldenburg; Jacob Nattermann; Jürgen K Rockstroh; Ulrich Spengler
Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients.
Clinical science (London, England : 1979) 2009;116(12):861-70.
2009: Martin Vogel; Jürgen K Rockstroh
Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
Current opinion in HIV and AIDS 2009;4(3):171-5.
2009: Martin Vogel; Norbert Bertram; Jan-Christian Wasmuth; Christoph Wyen; Esther Voigt; Carolynne Schwarze-Zander; Thomas Sudhop; Gerd Fätkenheuer; Jürgen K Rockstroh; Christoph Reichel
Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals.
The Journal of antimicrobial chemotherapy 2009;63(5):988-91.
2009: Martin Vogel; Emma Page; Mark Nelson; Jürgen K Rockstroh
Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges?
Journal of HIV therapy 2009;14(1):8-12.
2009: Golo Ahlenstiel; Rainer P Woitas; Agathe Iwan; Jacob Nattermann; Georg Feldmann; Jürgen K Rockstroh; Johannes Oldenburg; Bernd Kupfer; Tilman Sauerbruch; Ulrich Spengler
Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
Immunological investigations 2009;38(3-4):284-96.
2009: Golo Ahlenstiel; Rainer P Woitas; Agathe Iwan; Jacob Nattermann; Georg Feldmann; Jürgen K Rockstroh; Johannes Oldenburg; Bernd Kupfer; Tilman Sauerbruch; Ulrich Spengler
Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
Immunological investigations 2009;38(1):1-13.
2008: Jürgen K Rockstroh; J C Wasmuth
[Rational use of modern substances for the treatment of HIV-infection].
Der Internist 2008;49(12):1463-4, 1466-9.
2008: Jetske M Emmelkamp; Jürgen K Rockstroh
Maraviroc, risks and benefits: a review of the clinical literature.
Expert opinion on drug safety 2008;7(5):559-69.
2008: Jacob Nattermann; Martin Vogel; Hans Dieter Nischalke; Mark Danta; Golo Ahlenstiel; Monika Michalk; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.
AIDS (London, England) 2008;22(11):1287-92.
2008: S C Blass; S Ellinger; M Vogel; P Ingiliz; Ulrich Spengler; P Stehle; A von Ruecker; Jürgen K Rockstroh
Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism - a reason for glycemic control.
European journal of medical research 2008;13(5):209-14.
2008: Jürgen K Rockstroh; S Bhagani; Y Benhamou; RAFFAELE BRUNO; Stefan Mauss; L Peters; M Puoti; V Soriano; C Tural
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
HIV medicine 2008;9(2):82-8.
2008: Thomas Kuntzen; Cristina Tural; Bin Li; Georg Feldmann; Bernd Kupfer; Hans Dieter Nischalke; Bonaventura Clotet; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
AIDS (London, England) 2008;22(2):203-10.
2008: Vincent Soriano; Massimo Puoti; Pilar Garcia-Gascó; Jürgen K Rockstroh; Yves Benhamou; Pablo Barreiro; Barbara McGovern
Antiretroviral drugs and liver injury.
AIDS (London, England) 2008;22(1):1-13.
2008: Milos Opravil; Joseph Sasadeusz; David A Cooper; Jürgen K Rockstroh; Nathan Clumeck; Bonaventura Clotet; Julio Montaner; Francesca J Torriani; Jean DePamphilis; Douglas T Dieterich
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
Journal of acquired immune deficiency syndromes (1999) 2008;47(1):36-49.
2007: Michael P Manns; Graham R Foster; Jürgen K Rockstroh; Stefan Zeuzem; Fabien Zoulim; Michael Houghton
The way forward in HCV treatment--finding the right path.
Nature reviews. Drug discovery 2007;6(12):991-1000.
2007: Bernd Kupfer; Tobias Sing; Peter Schüffler; Rabea Hall; Ralf Kurz; Astrid McKeown; Karl-Eduard Schneweis; Wolfgang Eberl; Johannes Oldenburg; Hans H Brackmann; Jürgen K Rockstroh; Ulrich Spengler; Martin Däumer; Rolf Kaiser; Thomas Lengauer; Bertfried Matz
Fifteen years of env C2V3C3 evolution in six individuals infected clonally with human immunodeficiency virus type 1.
Journal of medical virology 2007;79(11):1629-39.
2007: Golo Ahlenstiel; Kirsten Roomp; Martin Däumer; Jacob Nattermann; Martin Vogel; Jürgen K Rockstroh; Niko Beerenwinkel; Rolf Kaiser; Hans Dieter Nischalke; Tilman Sauerbruch; Thomas Lengauer; Ulrich Spengler
Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level.
Clinical and vaccine immunology : CVI 2007;14(10):1266-73.
2007: Abdurrahman Sagir; Mark Oette; Rolf Kaiser; Martin Däumer; Gerd Fätkenheuer; Jürgen K Rockstroh; Heribert Knechten; Günther Schmutz; Martin Hower; Jetske Emmelkamp; Herbert Pfister; Dieter Häussinger
Trends of prevalence of primary HIV drug resistance in Germany.
The Journal of antimicrobial chemotherapy 2007;60(4):843-8.
2007: Bernd Kupfer; Bertfried Matz; Martin Däumer; Fabienne Roden; Jürgen K Rockstroh; Nazifa Qurishi; Ulrich Spengler; Rolf Kaiser
Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml.
Journal of medical virology 2007;79(10):1440-5.
2007: Jan-Christian Wasmuth; I Lambertz; Esther Voigt; Martin Vogel; C Hoffmann; David Burger; Jürgen K Rockstroh
Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity.
European journal of clinical pharmacology 2007;63(10):901-8.
2007: Jacob Nattermann; Martin Vogel; Thomas Berg; Mark Danta; Baumgarten Axel; Christoph Mayr; RAFFAELE BRUNO; Cristina Tural; Gerd Klausen; Bonaventura Clotet; Thomas Lutz; Frank Grünhage; Michael Rausch; Hans Dieter Nischalke; Knud Schewe; Bernhard Bienek; Georg Haerter; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients.
Hepatology (Baltimore, Md.) 2007;46(4):1016-25.
2007: Jan-Christian Wasmuth; E Rodermann; Esther Voigt; Martin Vogel; E Lauenroth-Mai; A Jessen; David Burger; Jürgen K Rockstroh
Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoring.
European journal of medical research 2007;12(7):289-94.
2007: Martin Vogel; Jürgen K Rockstroh
Hepatotoxicity and liver disease in the context of HIV therapy.
Current opinion in HIV and AIDS 2007;2(4):306-13.
2007: Kamila Wojcik; Martin Vogel; Esther Voigt; Nicola Speidel; Jörg C Kalff; Georg Goldmann; Johannes Oldenburg; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort.
AIDS (London, England) 2007;21(10):1363-5.
2007: Mark Oette; Rolf Kaiser; Martin Däumer; Gerd Fätkenheuer; Jürgen K Rockstroh; Heribert Knechten; D Mitrenga; Niko Beerenwinkel; Abdurrahman Sagir; Herbert Pfister; Dieter Häussinger
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Deutsche medizinische Wochenschrift (1946) 2007;132(18):977-82.
2007: M Vogel; Jürgen K Rockstroh
[Chronic HIV infection. Current therapeutic aspects].
Der Internist 2007;48(5):519-24; quiz 525.
2006: Marcus Altfeld; Elizabeth T Kalife; Ying Qi; Hendrik Streeck; Mathias Lichterfeld; Mary N Johnston; Nicole C Burgett; Martha E Swartz; Amy Yang; Galit Alter; Xu G Yu; Angela Meier; Jürgen K Rockstroh; Todd M Allen; Heiko Jessen; Eric S Rosenberg; Mary Carrington; Bruce D Walker
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.
PLoS medicine 2006;3(10):e403.
2006: Hendrik Streeck; Heiko Jessen; Galit Alter; Nickolas Teigen; Michael T Waring; Arne Jessen; Ingrid Stahmer; Jan van Lunzen; Mathias Lichterfeld; Xiaojiang Gao; Todd M Allen; Mary Carrington; Bruce D Walker; Jürgen K Rockstroh; Marcus Altfeld
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.
The Journal of infectious diseases 2006;194(6):734-9.
2006: Hendrik Streeck; Jürgen K Rockstroh
Challenges in the treatment of HIV and HCV coinfection.
Expert review of clinical immunology 2006;2(5):811-22.
2006: P Ingiliz; Beate Appenrodt; F Gruenhage; M Vogel; Henriette J Tschampa; Selçuk Tasci; Jürgen K Rockstroh
Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation.
HIV medicine 2006;7(6):411-4.
2006: Martin Vogel; Mathias Lichterfeld; D E Kaufmann; Stanley K Mui; M Altfeld; Esther Voigt; Golo Ahlenstiel; Bernd Kupfer; B Walker; Ulrich Spengler; Jürgen K Rockstroh
Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.
European journal of medical research 2006;11(7):273-8.
2006: Esther Voigt; Christian Schulz; Gerd Klausen; Joerg Goelz; Stefan Mauss; Guenther Schmutz; Heiko Jessen; Lutwin Weitner; Antonius Mutz; Dietmar Schranz; Jürgen K Rockstroh
Pegylated interferon alpha-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients.
The Journal of infection 2006;53(1):36-42.
2006: Oliver Schildgen; Hüseyin Sirma; Anneke Funk; Cynthia Olotu; Ulrike C Wend; Heinz Hartmann; Martin Helm; Jürgen K Rockstroh; Wulf R Willems; Hans Will; Wolfram H Gerlich
Variant of hepatitis B virus with primary resistance to adefovir.
The New England journal of medicine 2006;354(17):1807-12.
2006: Mark Oette; Rolf Kaiser; Martin Däumer; Ruth Petch; Gerd Fätkenheuer; Horst Carls; Jürgen K Rockstroh; Dirk Schmalöer; Jürgen Stechel; Torsten Feldt; Herbert Pfister; Dieter Häussinger
Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing.
Journal of acquired immune deficiency syndromes (1999) 2006;41(5):573-81.
2006: Jürgen K Rockstroh
Management of hepatitis C/HIV coinfection.
Current opinion in infectious diseases 2006;19(1):8-13.
2006: Martin Vogel; Jacob Nattermann; Axel Baumgarten; Gerd Klausen; Bernhard Bieniek; Knud Schewe; Heiko Jessen; Christoph Boesecke; Michael Rausch; Thomas Lutz; Stefan Fenske; Dietmar Schranzo; Tim Kümmerle; Christoph Schuler; Albert Theisen; Christoph Mayr; Thomas Seidel; Jürgen K Rockstroh
Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals.
Antiviral therapy 2006;11(8):1097-101.
2006: Jens Verheyen; Elena Litau; Tobias Sing; Martin Däumer; Melanie Balduin; Mark Oette; Gerd Fätkenheuer; Jürgen K Rockstroh; Ulrike Schuldenzucker; Daniel Hoffmann; Herbert Pfister; Rolf Kaiser
Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.
Antiviral therapy 2006;11(7):879-87.
2006: Dominique Salmon; Mathieu Robain; Jürgen K Rockstroh; Yves Benhamou
Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference.
Journal of hepatology 2006;44(1 Suppl):S2-5.
2006: Jürgen K Rockstroh
Influence of viral hepatitis on HIV infection.
Journal of hepatology 2006;44(1 Suppl):S25-7.
2005: Golo Ahlenstiel; Agathe Iwan; Jacob Nattermann; Karin Bueren; Jürgen K Rockstroh; Hans H Brackmann; Bernd Kupfer; Olfert Landt; Amnon Peled; Tilman Sauerbruch; Ulrich Spengler; Rainer P Woitas
Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional study.
World journal of gastroenterology : WJG 2005;11(48):7631-8.
2005: Jürgen K Rockstroh
New drugs for HIV therapy.
Journal of HIV therapy 2005;10(4):66-7.
2005: Rainer P Woitas; Bodo Stoschus; Birgit Terjung; Martin Vogel; Bernd Kupfer; Hans H Brackmann; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Hepatitis C-associated autoimmunity in patients coinfected with HIV.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(6):1114-21.
2005: Martin Vogel; Esther Voigt; Nico Schäfer; Georg Goldmann; Nicolas T Schwarz; Jörg C Kalff; Tilman Sauerbruch; Martin Wolff; Jürgen K Rockstroh; Ulrich Spengler
Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(12):1515-21.
2005: Melanie Balduin; Saleta Sierra; Martin Däumer; Jürgen K Rockstroh; Mark Oette; Gerd Fätkenheuer; Bernd Kupfer; Niko Beerenwinkel; Daniel Hoffmann; Joachim Selbig; Herbert Pfister; Rolf Kaiser
Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34(4):277-87.
2005: Todd M Allen; Marcus Altfeld; Shaun C Geer; Elizabeth T Kalife; Corey Moore; Kristin M O'Sullivan; Ivna Desouza; Margaret E Feeney; Robert L Eldridge; Erica L Maier; Daniel E Kaufmann; Matthew P Lahaie; Laura L Reyor; Giancarlo O Tanzi; Mary N Johnston; Christian Brander; Rika Draenert; Jürgen K Rockstroh; Heiko Jessen; Eric S Rosenberg; Simon Mallal; Bruce D Walker
Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
Journal of virology 2005;79(21):13239-49.
2005: Gerd Fätkenheuer; Anton L Pozniak; Margaret A Johnson; Andreas Plettenberg; Schlomo Staszewski; Andy I M Hoepelman; Michael S Saag; Frank-Detlef Goebel; Jürgen K Rockstroh; Bruce J Dezube; Tim M Jenkins; Christine Medhurst; John F Sullivan; Caroline Ridgway; Samantha Abel; Ian T James; Mike Youle; Elna van der Ryst
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
Nature medicine 2005;11(11):1170-2.
2005: Jan-Christian Wasmuth; Jürgen K Rockstroh
[Splenic infarct in a patient with HIV infection].
Medizinische Klinik (Munich, Germany : 1983) 2005;100(10):683-5.
2005: Jürgen K Rockstroh; Amanda Mocroft; Vincent Soriano; Cristina Tural; Marcello H Losso; Andrzej Horban; Ole Kirk; Andrew Phillips; bruno ledergerber; Jens Lundgren
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
The Journal of infectious diseases 2005;192(6):992-1002.
2005: Bernd Kupfer; Torsten Ruf; Bertfried Matz; Jacob Nattermann; Ulrich Spengler; Jürgen K Rockstroh; Hans H Brackmann; Johannes Blümel; Michael Tacke; Rolf Kaiser
Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34(1):42-7.
2005: Mathias Lichterfeld; Nazifa Qurishi; Christian Hoffmann; Bettina Hochdorfer; Norbert H Brockmeyer; Keikawus Arastéh; Stefan Mauss; Jürgen K Rockstroh
Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Infection 2005;33(3):140-7.
2005: Martin Vogel; Jürgen K Rockstroh
Safety of lopinavir/ritonavir for the treatment of HIV-infection.
Expert opinion on drug safety 2005;4(3):403-20.
2005: Mathias Lichterfeld; Susanne Haas; Hans-Peter Fischer; Esther Voigt; Jürgen K Rockstroh; Ulrich Spengler
Liver histopathology in human immunodeficiency virus-hepatitis C virus co-infected patients with fatal liver disease.
Journal of gastroenterology and hepatology 2005;20(5):739-45.
2005: Mathias Lichterfeld; Norbert Schmeisser; Nazifa Qurishi; Martin Vogel; Hans-Hermann Brackmann; Ulrich Spengler; Jürgen K Rockstroh
Clinical outcomes of HIV-HCV co-infection in a large cohort of hemophiliac patients.
The Journal of infection 2005;50(3):221-8.
2005: Martin Vogel; Bernhard Bieniek; Heiko Jessen; Carl Knud Schewe; C Hoffmann; A Baumgarten; A Kroidl; J R Bogner; Ulrich Spengler; Jürgen K Rockstroh
Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases.
Journal of viral hepatitis 2005;12(2):207-11.
2004: Oliver Schildgen; Carl Knud Schewe; Martin Vogel; Martin Däumer; Rolf Kaiser; Lutwin Weitner; Bertfried Matz; Jürgen K Rockstroh
Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment.
AIDS (London, England) 2004;18(17):2325-7.
2004: Jürgen K Rockstroh; Ulrich Spengler
[HIV-infection: modern antiretroviral therapy].
Deutsche medizinische Wochenschrift (1946) 2004;129(37):1921-4.
2004: Francesca J Torriani; Maribel Rodriguez-Torres; Jürgen K Rockstroh; Eduardo Lissen; Juan Gonzalez-García; Adriano Lazzarin; Giampiero Carosi; Joseph Sasadeusz; Christine Katlama; Julio Montaner; Hoel Sette; Sharon Passe; Jean De Pamphilis; Frank Duff; Uschi Marion Schrenk; Douglas T Dieterich
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
The New England journal of medicine 2004;351(5):438-50.
2004: Hans Dieter Nischalke; Jacob Nattermann; Mathias Lichterfeld; Rainer P Woitas; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Rapid determination of the Delta32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by lightcycler real-time polymerase chain reaction.
AIDS research and human retroviruses 2004;20(7):750-4.
2004: Martin Vogel; Esther Voigt; Hans-Christoph Michaelis; Thomas Sudhop; Martin Wolff; Andreas Türler; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(7):939-44.
2004: Jürgen K Rockstroh; Ulrich Spengler
HIV and hepatitis C virus co-infection.
The Lancet infectious diseases 2004;4(7):437-44.
2004: Mark Oette; Rolf Kaiser; Martin Däumer; D Akbari; Gerd Fätkenheuer; Jürgen K Rockstroh; Jürgen Stechel; A Rieke; Stefan Mauss; D Schmalöer; Klaus Göbels; Christoph Vogt; Matthias Wettstein; Dieter Häussinger
Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany.
European journal of medical research 2004;9(5):273-8.
2004: Jürgen K Rockstroh; Stefan Mauss
Clinical perspective of fusion inhibitors for treatment of HIV.
The Journal of antimicrobial chemotherapy 2004;53(5):700-2.
2004: Jan-Christian Wasmuth; Charles J L la Porte; Katrin Schneider; David Burger; Jürgen K Rockstroh
Comparison of two reduced-dose regimens of indinavir (600 mg vs 400 mg twice daily) and ritonavir (100 mg twice daily) in healthy volunteers (COREDIR).
Antiviral therapy 2004;9(2):213-20.
2004: Esther Voigt; Jan-Christian Wasmuth; Martin Vogel; Stefan Mauss; Guenther Schmutz; Rolf Kaiser; Jürgen K Rockstroh
Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week results.
Infection 2004;32(2):82-8.
2004: Jan-Christian Wasmuth; Hans Dieter Nischalke; Alexander Jütte; Gerd Fätkenheuer; Bernd Salzberger; Tilman Sauerbruch; Ulrich Spengler; Jürgen K Rockstroh; Franz Ludwig Dumoulin
Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAART.
Antiviral research 2004;61(3):207-12.
2004: Stefan Mauss; S Scholten; Eva Wolf; Florian Berger; Guenther Schmutz; Hans Jaeger; Michael Kurowski; Jürgen K Rockstroh
A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir.
HIV medicine 2004;5(1):15-7.
2003: Marcus Altfeld; Marylyn M Addo; Eric S Rosenberg; Frederick Hecht; Paul K Lee; Martin Vogel; Xu G Yu; Rika Draenert; Mary N Johnston; Daryld Strick; Todd M Allen; Margaret E Feeney; James O Kahn; Rafick-Pierre Sekaly; Jay A Levy; Jürgen K Rockstroh; Philip J R Goulder; Bruce D Walker
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
AIDS (London, England) 2003;17(18):2581-91.
2003: Nazifa Qurishi; Christina Kreuzberg; Guido Lüchters; Wolfgang Effenberger; Bernd Kupfer; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.
Lancet 2003;362(9397):1708-13.
2003: Urban J Scheuring; Hanns Martin Seitz; Axel Wellmann; Joachim H Hartlapp; Dennis Tappe; Klaus Brehm; Ulrich Spengler; Tilmann Sauerbruch; Jürgen K Rockstroh
Long-term benzimidazole treatment of alveolar echinococcosis with hematogenic subcutaneous and bone dissemination.
Medical microbiology and immunology 2003;192(4):193-5.
2003: Jürgen K Rockstroh
Management of hepatitis B and C in HIV co-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2003;34 Suppl 1():S59-65.
2003: Rob E Aarnoutse; Jan-Christian Wasmuth; Gerd Fätkenheuer; Katrin Schneider; Karina Schmitz; Theo M de Boo; Peter Reiss; Yechiel A Hekster; David Burger; Jürgen K Rockstroh
Administration of indinavir and low-dose ritonavir (800/100 mg twice daily) with food reduces nephrotoxic peak plasma levels of indinavir.
Antiviral therapy 2003;8(4):309-14.
2003: Ingo G H Schmidt-Wolf; Jürgen K Rockstroh; Uwe Schlegel; Hendrik Pels; Ulrich Mey; John Strehl; Rudolf Weiss; Dieter Huhn
Treatment options of AIDS-related lymphoma.
Expert opinion on pharmacotherapy 2003;4(8):1331-43.
2003: Charles J L la Porte; Jan-Christian Wasmuth; Katrin Schneider; Jürgen K Rockstroh; David Burger
Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy.
AIDS (London, England) 2003;17(11):1700-2.
2003: Mathias Lichterfeld; Hans Dieter Nischalke; Jan van Lunzen; Jennifer Söhne; Norbert Schmeisser; Rainer P Woitas; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS.
Clinical immunology (Orlando, Fla.) 2003;107(1):55-9.
2003: Mathias Lichterfeld; Jürgen K Rockstroh
[Antiretroviral treatment of HIV infected patients].
Medizinische Monatsschrift für Pharmazeuten 2003;26(4):111-21; quiz 121-2.
2003: Jan-Christian Wasmuth; Frank Hackbarth; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapy.
HIV medicine 2003;4(2):111-9.
2003: Mathias Lichterfeld; Andrej Wöhrmann; Norbert Schmeisser; Gerd Fätkenheuer; Bernd Salzberger; Christoph Wyen; K Schmitz; Tilman Sauerbruch; Jürgen K Rockstroh
Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy.
European journal of medical research 2003;8(2):56-60.
2003: Mathias Lichterfeld; Hans-Peter Fischer; Ulrich Spengler; Jürgen K Rockstroh
[Fatty liver and increased serum lactate in a woman with HIV].
Deutsche medizinische Wochenschrift (1946) 2003;128(3):81-4.
2002: Jan-Christian Wasmuth; Kirsten Schliefer; Christian Scheurlen; Thomas Sudhop; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Enteric dysfunction in patients with asymptomatic HIV-infection versus patients with hypoproteinemia/hypalbuminemia and advanced HIV-infection.
European journal of medical research 2002;7(12):536-42.
2002: Jürgen K Rockstroh; Mannah Mudar; Mathias Lichterfeld; Hans Dieter Nischalke; Gerd Klausen; Jörg Gölz; Stefan Dupke; Gundula Notheis; Luca Stein; Stefan Mauss
Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients.
AIDS (London, England) 2002;16(15):2083-5.
2002: Esther Voigt; A Wickesberg; Jan-Christian Wasmuth; Peter Gute; L Locher; Bernd Salzberger; Andrej Wöhrmann; A Adam; Lutwin Weitner; Jürgen K Rockstroh
First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results.
HIV medicine 2002;3(4):277-82.
2002: Rainer P Woitas; Golo Ahlenstiel; Agathe Iwan; Jürgen K Rockstroh; Hans H Brackmann; Bernd Kupfer; Bertfried Matz; Ruth Offergeld; Tilman Sauerbruch; Ulrich Spengler
[Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?].
Deutsche medizinische Wochenschrift (1946) 2002;127(36):1807-12.
2002: Ingo G H Schmidt-Wolf; Jürgen K Rockstroh; Uwe Schlegel; Hendrik Pels; R Weiss; Dieter Huhn
New aspects in the treatment of AIDS-related lymphoma.
European journal of medical research 2002;7(7):295-303.
2002: Rainer P Woitas; Martin Sippel; Eva-Maria Althausen; Hans H Brackmann; Bettina Kochan; Bertfried Matz; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Differential expansion of T-cell receptor variable beta subsets after antigenic stimulation in patients with different outcomes of hepatitis C infection.
Immunology 2002;106(3):419-27.
2002: Jan-Christian Wasmuth; Desamparados Oliver y Miñarro; Angela Homrighausen; Ludger Leifeld; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Phospholipid autoantibodies and the antiphospholipid antibody syndrome: diagnostic accuracy of 23 methods studied by variation in ROC curves with number of clinical manifestations.
Clinical chemistry 2002;48(7):1004-10.
2002: Mathias Lichterfeld; Ludger Leifeld; Hans Dieter Nischalke; Jürgen K Rockstroh; Lothar Hess; Tilman Sauerbruch; Ulrich Spengler
Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
The Journal of infectious diseases 2002;185(12):1803-7.
2002: Rainer P Woitas; Golo Ahlenstiel; Agathe Iwan; Jürgen K Rockstroh; Hans H Brackmann; Bernd Kupfer; Bertfried Matz; Ruth Offergeld; Tilman Sauerbruch; Ulrich Spengler
Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
Gastroenterology 2002;122(7):1721-8.
2002: Jan-Christian Wasmuth; Christina Herhaus; Katja Römer; Bernd Salzberger; Rolf Kaiser; Kirsten Schliefer; Esther Voigt; Jürgen K Rockstroh
Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.
AIDS (London, England) 2002;16(7):1077-8.
2002: Jürgen K Rockstroh
[Hepatitis C and HIV coinfection. Current aspects of therapy].
MMW Fortschritte der Medizin 2002;144 Suppl 1():30-2.
2002: Ulrich Spengler; Mathias Lichterfeld; Jürgen K Rockstroh
Antiretroviral drug toxicity -- a challenge for the hepatologist?
Journal of hepatology 2002;36(2):283-94.
2002: Mathias Lichterfeld; Hans Dieter Nischalke; F Bergmann; W Wiesel; A Rieke; Albert Theisen; Gerd Fätkenheuer; Mark Oette; Horst Carls; Stefan Fenske; M Nadler; Heribert Knechten; Jan-Christian Wasmuth; Jürgen K Rockstroh
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapy.
HIV medicine 2002;3(1):37-43.
2002: Mathias Lichterfeld; C Lorenz; Hans Dieter Nischalke; Christian Scheurlen; Tilman Sauerbruch; Jürgen K Rockstroh
Decreased prevalence of Helicobacter pylori infection in HIV patients with AIDS defining diseases.
Zeitschrift für Gastroenterologie 2002;40(1):11-4.
2001: MP Look; R Riezler; Heiner K. Berthold; SP Stabler; Kirsten Schliefer; R H Allen; Tilman Sauerbruch; Jürgen K Rockstroh
Decrease of elevated N,N-dimethylglycine and N-methylglycine in human immunodeficiency virus infection during short-term highly active antiretroviral therapy.
Metabolism: clinical and experimental 2001;50(11):1275-81.
2001: Holger Palmedo; Jürgen K Rockstroh; M Bangard; Kirsten Schliefer; Jörn H Risse; Christian Menzel; Hans-Jürgen Biersack
Painful multifocal arthritis: therapy with rhenium 186 hydroxyethylidenediphosphonate ((186)Re HEDP) after failed treatment with medication--initial results of a prospective study.
Radiology 2001;221(1):256-60.
2000: J Koopmann; Frank Dombrowski; Jürgen K Rockstroh; Ulrich Pfeifer; Tilman Sauerbruch; U Spengler
Fatal pneumonia in an AIDS patient coinfected with adenovirus and Pneumocystis carinii.
Infection 2000;28(5):323-5.
2000: MP Look; M Altfeld; Karl-Anton Kreuzer; R Riezler; SP Stabler; R H Allen; Tilman Sauerbruch; Jürgen K Rockstroh
Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease.
AIDS research and human retroviruses 2000;16(13):1215-21.
2000: MP Look; R Riezler; Christoph Reichel; Karl August Brensing; Jürgen K Rockstroh; SP Stabler; Ulrich Spengler; Heiner K. Berthold; Tilman Sauerbruch
Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase?
Scandinavian journal of gastroenterology 2000;35(8):866-72.
2000: Franz Ludwig Dumoulin; Hans Dieter Nischalke; Ludger Leifeld; Annette von dem Bussche; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards.
Journal of immunological methods 2000;241(1-2):109-19.
2000: Jürgen K Rockstroh; F Bergmann; W Wiesel; A Rieke; A Thiesen; Gerd Fätkenheuer; Mark Oette; Horst Carls; Stefan Fenske; M Nadler; Heribert Knechten
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study Group.
AIDS (London, England) 2000;14(9):1181-5.
2000: Ingrid Reiter-Owona; H Seitz; U Gross; Monika Sahm; Jürgen K Rockstroh; Hanns M Seitz
Is stage conversion the initiating event for reactivation of Toxoplasma gondii in brain tissue of AIDS patients?
The Journal of parasitology 2000;86(3):531-6.
2000: Kirsten Schliefer; W Dieter Paar; G Aydemir; Martin Wolff; Jürgen K Rockstroh; Ulrich Spengler; Tilman Sauerbruch
[Orthotopic liver transplantation in a 33-year-old patient with fulminant hepatitis B and HIV infection].
Deutsche medizinische Wochenschrift (1946) 2000;125(17):523-6.
2000: M Altfeld; M M Addo; Karl-Anton Kreuzer; Jürgen K Rockstroh; Franz Ludwig Dumoulin; Kirsten Schliefer; Ludger Leifeld; Tilman Sauerbruch; Ulrich Spengler
T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions.
Journal of acquired immune deficiency syndromes (1999) 2000;23(4):287-94.
2000: D Schleiermacher; Jürgen K Rockstroh; K Wilhelm; U Spengler
[Mycobacterium avium infection presenting as a mass in the right lung].
Medizinische Klinik (Munich, Germany : 1983) 2000;95(2):93-5.
2000: Jan-Christian Wasmuth; K H Klein; Frank Hackbarth; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Prediction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosis.
Journal of acquired immune deficiency syndromes (1999) 2000;23(1):44-51.
1999: Heiner K. Berthold; Klaus G Parhofer; MM Ritter; M Addo; Jan-Christian Wasmuth; Kirsten Schliefer; Ulrich Spengler; Jürgen K Rockstroh
Influence of protease inhibitor therapy on lipoprotein metabolism.
Journal of internal medicine 1999;246(6):567-75.
1999: Kirsten Schliefer; H O Gümbel; Jürgen K Rockstroh; Ulrich Spengler
Management of progressive outer retinal necrosis with cidofovir in a human immunodeficiency virus-infected patient.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(3):684-5.
1999: Rainer P Woitas; Jürgen K Rockstroh; I Beier; G Jung; Bettina Kochan; Bertfried Matz; Hans H Brackmann; Tilman Sauerbruch; Ulrich Spengler
Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients.
AIDS (London, England) 1999;13(11):1313-22.
1999: Jürgen K Rockstroh; M Altfeld; Bernd Kupfer; Rolf Kaiser; G Fätkenheuer; B Salzberger; Karl-Eduard Schneweis; Ulrich Spengler
Failure of double protease inhibitor therapy as a salvage therapy for HIV-infected patients resistant to conventional triple therapy.
European journal of medical research 1999;4(7):271-4.
1999: Bernd Kupfer; Rolf Kaiser; Hans H Brackmann; Wolfgang Effenberger; Jürgen K Rockstroh; Bertfried Matz; Karl-Eduard Schneweis
Protection against parenteral HIV-1 infection by homozygous deletion in the C-C chemokine receptor 5 gene.
AIDS (London, England) 1999;13(9):1025-8.
1999: Franz Ludwig Dumoulin; M Altfeld; Jürgen K Rockstroh; Ludger Leifeld; Tilman Sauerbruch; Ulrich Spengler
Semiquantitation of human chemokine mRNA levels with a newly constructed multispecific competitor fragment.
Journal of immunological methods 1999;224(1-2):61-7.
1998: Ulrich Spengler; Jürgen K Rockstroh
Hepatitis C in the patient with human immunodeficiency virus infection.
Journal of hepatology 1998;29(6):1023-30.
1998: Jürgen K Rockstroh; Karl-Anton Kreuzer; Tilman Sauerbruch; Ulrich Spengler
Protein levels of interleukin-12 p70 holomer, its p40 chain and interferon-gamma during advancing HIV infection.
The Journal of infection 1998;37(3):282-6.
1998: Bernd Kupfer; Rolf Kaiser; Jürgen K Rockstroh; Bertfried Matz; Karl-Eduard Schneweis
Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count.
Journal of medical virology 1998;56(3):259-63.
1998: Rainer P Woitas; Jürgen K Rockstroh; Albert Theisen; Claudia C Leutner; Tilman Sauerbruch; Ulrich Spengler
Changing role of invasive aspergillosis in AIDS--a case control study.
The Journal of infection 1998;37(2):116-22.
1998: M Altfeld; Jürgen K Rockstroh; Marylyn M Addo; Bernd Kupfer; I Pult; Hans Will; Ulrich Spengler
Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal.
Journal of hepatology 1998;29(2):306-9.
1998: Jürgen K Rockstroh; Rainer P Woitas; Ulrich Spengler
Human immunodeficiency virus and hepatitis C virus coinfection.
European journal of medical research 1998;3(6):269-77.
1998: Jürgen K Rockstroh; Rainer P Woitas; Hans H Brackmann; Bernd Kupfer; Rolf Kaiser; Karl-Eduard Schneweis; Thomas Sudhop; Ulrich Spengler
In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count.
European journal of medical research 1998;3(5):223-30.
1998: MP Look; Jürgen K Rockstroh; GS Rao; S Barton; H Lemoch; R Kaiser; Bernd Kupfer; Thomas Sudhop; Ulrich Spengler; Tilman Sauerbruch
Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study.
European journal of clinical investigation 1998;28(5):389-97.
1998: Ingrid Reiter-Owona; R Bialek; Jürgen K Rockstroh; Hanns M Seitz
The probability of acquiring primary Toxoplasma infection in HIV-infected patients: results of an 8-year retrospective study.
Infection 1998;26(1):20-5.
1997: Karl-Anton Kreuzer; J M Dayer; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
Clinical and experimental immunology 1997;109(1):54-8.
1997: MP Look; Jürgen K Rockstroh; GS Rao; Karl-Anton Kreuzer; S Barton; H Lemoch; Thomas Sudhop; J Hoch; K Stockinger; Ulrich Spengler; Tilman Sauerbruch
Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection.
European journal of clinical nutrition 1997;51(4):266-72.
1997: Karl-Anton Kreuzer; Jürgen K Rockstroh; Wolfgang Jelkmann; Albert Theisen; Ulrich Spengler; Tilman Sauerbruch
Inadequate erythropoietin response to anaemia in HIV patients: relationship to serum levels of tumour necrosis factor-alpha, interleukin-6 and their soluble receptors.
British journal of haematology 1997;96(2):235-9.
1997: MP Look; Jürgen K Rockstroh; GS Rao; Karl-Anton Kreuzer; Ulrich Spengler; Tilman Sauerbruch
Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection.
Biological trace element research 1997;56(1):31-41.